The FDA notes that compounded injectable products containing GHK-Cu may carry immunogenicity concerns related to aggregation and peptide impurities, while human safety data for injectable routes remain limited
Clinical trials revealed the most common side effects were nausea, diarrhea, vomiting, decreased appetite, dyspepsia, and constipation
Vitamine B1
In SLE, the body's immune system produces antibodies against self-protein, particularly against proteins in the cell nucleus
But that business exists not because Hims has developed and gained approval for such a drug, but rather due to a regulatory quirk: if the FDA determines there is a shortage of a particular drug, so-called compounding pharmacies can produce non-brand name versions of FDA-approved drugs, which companies like Hims can then offer patients at a cheaper price than name-brand versions
*Correspondence: Hossein Motedayyen, [email protected]